Clinical trials
Myopia trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
137 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 7 |
| 2009 | 6 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 7 |
| 2015 | 2 |
| 2016 | 8 |
| 2017 | 2 |
| 2018 | 9 |
| 2019 | 9 |
| 2020 | 16 |
| 2021 | 9 |
| 2022 | 24 |
| 2023 | 17 |
| 2024 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 137 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Eye Disease Prevention and Treatment Center | 11 |
| Sun Yat-sen University | 10 |
| Tianjin Eye Hospital | 10 |
| Zhongshan Ophthalmic Center, Sun Yat-sen University | 9 |
| Technolas Perfect Vision GmbH | 4 |
| Yonsei University | 4 |
| He Eye Hospital | 3 |
| Aier School of Ophthalmology, Central South University | 2 |
| Brien Holden Vision Institute | 2 |
| Democritus University of Thrace | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myopia | 137 |
| Refractive Errors | 21 |
| Astigmatism | 20 |
| Hyperopia | 15 |
| Presbyopia | 8 |
| Glaucoma | 6 |
| Myopia, Degenerative | 6 |
| Cataract | 3 |
| Corneal Diseases | 3 |
| Eye Diseases | 3 |
Trials
Showing 26 to 50 of 137. Each trial links to its page on Pharma Observatory.
37 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.